Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine

References

• Estey E, Döhner H. Acute myeloid leukaemia. The Lancet. 2006;368:1894–1907. doi: 10.1016/S0140-6736(06)69780-8
   PubMed Web of Science ®Google Scholar
• Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. New England J Med. 2015;373:1136–1152. doi: 10.1056/NEJMra1406184
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Abdel-Wahab O, Lu C, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 2011;18:553–567. doi: 10.1016/j.ccr.2010.11.015
   Web of Science ®Google Scholar
• Shipley JL, Butera JN. Acute myelogenous leukemia. Exp Hematol. 2009;37:649–658. doi: 10.1016/j.exphem.2009.04.002
   PubMed Web of Science ®Google Scholar
• Chaudhury SS, Morison JK, Gibson BES, et al. Insights into cell ontogeny, age, and acute myeloid leukemia. Exp Hematol. 2015;43:745–755. doi: 10.1016/j.exphem.2015.05.008
   PubMed Web of Science ®Google Scholar
• Pan X-N, Chen J-J, Wang L-X, et al. Inhibition of c-Myc overcomes cytotoxic drug resistance in acute myeloid leukemia cells by promoting differentiation. Plos One. 2014;9:e105381. doi: 10.1371/journal.pone.0105381
   PubMed Web of Science ®Google Scholar
• Li L, Osdal T, Ho Y, et al. SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell. 2014;15:431–446. doi: 10.1016/j.stem.2014.08.001
   PubMed Web of Science ®Google Scholar
• Illmer T, Schaich M, Platzbecker U, et al. P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate. Leukemia. 2004;18:401–408. doi: 10.1038/sj.leu.2403257
   PubMed Web of Science ®Google Scholar
• Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703–707. doi: 10.1016/j.cell.2008.08.021
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg Robert A. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Knoechel B, Aster Jon C. Metabolic mechanisms of drug resistance in leukemia. Cell Metab. 2015;22:759–760. doi: 10.1016/j.cmet.2015.10.005
   PubMed Web of Science ®Google Scholar
• Omene CO, Wu J, Frenkel K. Caffeic acid phenethyl ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells. Invest New Drugs. 2012;30:1279–1288. doi: 10.1007/s10637-011-9667-8
   PubMed Web of Science ®Google Scholar
• Wu J, Omene C, Karkoszka J, et al. Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of Anti-tumor effects in preclinical models of human breast cancer. Cancer Lett. 2011;308:43–53. doi: 10.1016/j.canlet.2011.04.012
   PubMed Web of Science ®Google Scholar
• Chen Y-J, Shiao M-S, Wang S-Y. The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anti-Cancer Drugs. 2001;12:143–149. doi: 10.1097/00001813-200102000-00008
   PubMed Web of Science ®Google Scholar
• Cavaliere V, Papademetrio DL, Lorenzetti M, et al. Caffeic acid phenylethyl ester and MG-132 have apoptotic and antiproliferative effects on leukemic cells but not on normal mononuclear cells. Translational Oncol. 2009;2:46–58. doi: 10.1593/tlo.08202
   PubMed Web of Science ®Google Scholar
• Cavaliere V, Papademetrio DL, Lombardo T, et al. Caffeic acid phenylethyl ester and MG132, two novel nonconventional chemotherapeutic agents, induce apoptosis of human leukemic cells by disrupting mitochondrial function. Targeted Oncol. 2014;9:25–42. doi: 10.1007/s11523-013-0256-y
   PubMed Web of Science ®Google Scholar
• Chen Y-J, Shiao M-S, Hsu M-L, et al. Effect of caffeic acid phenethyl ester, an antioxidant from propolis, on inducing apoptosis in human leukemic HL-60 cells. J Agric Food Chem. 2001;49:5615–5619. doi: 10.1021/jf0107252
   PubMed Web of Science ®Google Scholar
• Qin T, Youssef EM, Jelinek J, et al. Effect of Cytarabine and Decitabine in combination in human leukemic cell lines. Clin Cancer Res. 2007;13:4225. doi: 10.1158/1078-0432.CCR-06-2762
   PubMed Web of Science ®Google Scholar
• Chen J-H, Shao Y, Huang M-T, et al. Inhibitory effect of caffeic acid phenethyl ester on human leukemia HL-60 cells. Cancer Lett. 1996;108:211–214. doi: 10.1016/S0304-3835(96)04425-4
   PubMed Web of Science ®Google Scholar
• Petriz J, Garcia-Lopez J. Flow cytometric analysis of P-glycoprotein function using rhodamine 123. Leukemia. 1997;11:1124–1130 doi: 10.1038/sj.leu.2400659
   PubMed Web of Science ®Google Scholar
• Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood. 2006;107:3481–3485. doi: 10.1182/blood-2005-09-3724
   PubMed Web of Science ®Google Scholar
• Lee Y-J, Kuo H-C, Chu C-Y, et al. Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem Pharm. 2003;66:2281–2289. doi: 10.1016/j.bcp.2003.07.014
   PubMed Web of Science ®Google Scholar
• Xiang D, Wang D, He Y, et al. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the β-catenin/T-cell factor signaling. Anti-Cancer Drugs. 2006;17:753–762. doi: 10.1097/01.cad.0000224441.01082.bb
   PubMed Web of Science ®Google Scholar
• Lee Y-Y, Kao C-L, Tsai P-H, et al. Caffeic acid phenethyl ester preferentially enhanced radiosensitizing and increased oxidative stress in medulloblastoma cell line. Child's Nerv Syst. 2008;24:987–994. doi: 10.1007/s00381-008-0636-2
   PubMed Web of Science ®Google Scholar
• Jin U-H, Song K-H, Motomura M, et al. Caffeic acid phenethyl ester induces mitochondria-mediated apoptosis in human myeloid leukemia U937 cells. Mol Cell Biochem. 2008;310:43–48. doi: 10.1007/s11010-007-9663-7
   PubMed Web of Science ®Google Scholar
• Watabe M, Hishikawa K, Takayanagi A, et al. Caffeic acid phenethyl ester induces apoptosis by inhibition of NFκB and activation of Fas in human breast cancer MCF-7 cells. J Biol Chem. 2004;279:6017–6026. doi: 10.1074/jbc.M306040200
   PubMed Web of Science ®Google Scholar
• Kanno S-I, Higurashi A, Watanabe Y, et al. Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines. Toxicol Lett. 2004;152:149–158.
   PubMed Web of Science ®Google Scholar
• Liang H, Zheng Q-L, Fang P, et al. Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells. Sci Rep. 2017;7:40361. doi: 10.1038/srep40361
   PubMed Web of Science ®Google Scholar
• Hauge M, Bruserud Ø, Hatfield KJ. Targeting of cell metabolism in human acute myeloid leukemia – more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling? Eur J Haematol. 2016;96:211–221. doi: 10.1111/ejh.12690
   PubMed Web of Science ®Google Scholar
• Schieke SM, Phillips D, McCoy JP, et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem. 2006;281:27643–27652. doi: 10.1074/jbc.M603536200
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029–1033. doi: 10.1126/science.1160809
   PubMed Web of Science ®Google Scholar
• Lee ES, Uhm K-O, Lee YM, et al. CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells. Biochem Biophys Res Commun. 2007;361:854–858. doi: 10.1016/j.bbrc.2007.07.068
   PubMed Web of Science ®Google Scholar
• Demaria M, Giorgi C, Lebiedzinska M, et al. A STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction. Aging. 2010;2:823–842. doi: 10.18632/aging.100232
   PubMedGoogle Scholar
• Poli V, Camporeale A. STAT3-mediated metabolic reprograming in cellular transformation and implications for drug resistance. Front Oncol. 2015;5:121. doi: 10.3389/fonc.2015.00121
   PubMed Web of Science ®Google Scholar